Surgical Science Sweden AB (ST:SUS) — Market Cap & Net Worth
Market Cap & Net Worth: Surgical Science Sweden AB (SUS)
Surgical Science Sweden AB (ST:SUS) has a market capitalization of $180.22 Million (Skr1.67 Billion) as of May 2, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #16931 globally and #281 in its home market, demonstrating a -9.14% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Surgical Science Sweden AB's stock price Skr32.82 by its total outstanding shares 51026236 (51.03 Million). Analyse Surgical Science Sweden AB cash conversion from operations to see how efficiently the company converts income to cash.
Surgical Science Sweden AB Market Cap History: 2017 to 2026
Surgical Science Sweden AB's market capitalization history from 2017 to 2026. Data shows growth from $80.59 Million to $180.22 Million (12.83% CAGR).
Surgical Science Sweden AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Surgical Science Sweden AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.97x
Surgical Science Sweden AB's market cap is 0.97 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.50x
Surgical Science Sweden AB's market cap is 6.50 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $80.59 Million | $57.98 Million | -$2.26 Million | 1.39x | N/A |
| 2018 | $107.45 Million | $65.70 Million | -$4.52 Million | 1.64x | N/A |
| 2019 | $455.59 Million | $101.52 Million | $12.60 Million | 4.49x | 36.16x |
| 2020 | $502.33 Million | $104.80 Million | $15.61 Million | 4.79x | 32.19x |
| 2021 | $1.52 Billion | $366.78 Million | $86.25 Million | 4.15x | 17.64x |
| 2022 | $897.40 Million | $802.54 Million | $187.97 Million | 1.12x | 4.77x |
| 2023 | $1.00 Billion | $882.85 Million | $233.97 Million | 1.14x | 4.28x |
| 2024 | $856.08 Million | $884.09 Million | $131.65 Million | 0.97x | 6.50x |
Competitor Companies of SUS by Market Capitalization
Companies near Surgical Science Sweden AB in the global market cap rankings as of May 2, 2026.
Key companies related to Surgical Science Sweden AB by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #926 globally with a market cap of $28.21 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #2225 globally with a market cap of $10.06 Billion USD ( AU$14.22 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2339 globally with a market cap of $9.34 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2447 globally with a market cap of $8.82 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #926 | Veeva Systems Inc Class A | NYSE:VEEV | $28.21 Billion | $171.60 |
| #2225 | Pro Medicus Ltd | AU:PME | $10.06 Billion | AU$136.16 |
| #2339 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $9.34 Billion | $55.00 |
| #2447 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $8.82 Billion | $52.58 |
Surgical Science Sweden AB Historical Marketcap From 2017 to 2026
Between 2017 and today, Surgical Science Sweden AB's market cap moved from $80.59 Million to $ 180.22 Million, with a yearly change of 12.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr180.22 Million | +0.98% |
| 2025 | Skr178.47 Million | -79.15% |
| 2024 | Skr856.08 Million | -14.58% |
| 2023 | Skr1.00 Billion | +11.67% |
| 2022 | Skr897.40 Million | -41.01% |
| 2021 | Skr1.52 Billion | +202.83% |
| 2020 | Skr502.33 Million | +10.26% |
| 2019 | Skr455.59 Million | +324.00% |
| 2018 | Skr107.45 Million | +33.33% |
| 2017 | Skr80.59 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Surgical Science Sweden AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $180.22 Million USD |
| MoneyControl | $180.22 Million USD |
| MarketWatch | $180.22 Million USD |
| marketcap.company | $180.22 Million USD |
| Reuters | $180.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Surgical Science Sweden AB
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator … Read more